Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.00
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.50 (16.667%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
SYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU Judgment – Company Response

9 Feb 2024 07:59

RNS Number : 6416C
Symphony Environmental Tech. PLC
09 February 2024
 

9 February 2024

 

Symphony Environmental Technologies plc

("Symphony" or the "Company")

 

EU Judgment - Company Response

 

Symphony Environmental Technologies plc (AIM: SYM), makes this further announcement following the judgment of the General Court (the "Court") of the European Union ("EU") delivered on 31 January 2024 (the "Judgment").

THE JUDGMENT

(1) the Judgment and ruling of the Court was as to whether the Defendants had acted within the limits of their discretion with regard to the amendment to the Directive. The claim was for compensation focussed on the legality of their conduct.

(2) The Court found that the Defendants had not exceeded the limits of their discretion, so compensation was not awarded to Symphony.

(3) This Judgment was not an assessment of the effectiveness of the d2w technologies. The Court took into account only the information that was available at the time the Directive was adopted and did not include further studies that have supported the d2w technology and the distinction between oxo-biodegradable and oxo-degradable plastics. Nor did it include any expert evidence for which the Claimants had paid, nor the opinion of the EU Chemicals Agency as to the formation of microplastics.

(4) The distinction of d2w from being captured under the Directive is supported by the opinion of Symphony's King's Counsel following the Judgment, and it is Symphony's view in conjunction with that opinion that d2w should not be captured within the EU prohibition.

THE BUSINESS

d2w technology had not been widely used in the EU for several years, and the lengthy legal process and Judgment has therefore very little effect on Symphony's existing business. 

The Directors of Symphony believe that a key reason behind the lack of use of d2w in the EU is the wording of the amendment to Article 5 of the draft Directive inserted at a late stage in one of the committees of the European Parliament, which led to confusion in the market place with no distinction being made between oxo-degradable plastic and the oxo-biodegradable technology used in d2w. 

Symphony was not able to change the wording of the Directive, which resulted in the Board finding it necessary to file a claim for compensation. In the Judgment, the Court has cited the CEN definition TR15351 which shows that oxo-degradable and oxo-biodegradable plastic are different materials. The Company will publish a detailed note on the Judgment next week, which will be available on its website.

OVERVIEW

The problem with plastic is that a lot of it gets into the open environment, where it creates persistent microplastics. Symphony had therefore developed a method of making plastic so that it converts into biodegradable materials and biodegrades much more quickly if it becomes litter at the end of its useful life. This technology (branded d2w®) has been in use around the world for the last 15 years, and is considered by Symphony to be the only way to prevent plastic which has escaped into the open environment from accumulating there for decades.

Symphony's d2w and other approved brands are mandatory for a wide range of plastic products in Saudi Arabia, the United Arab Emirates, and other countries, who have carried out their own due-diligence on the technology, supported by robust international standards to prove biodegradability, recyclability, and non-toxicity. Symphony also sells d2w in many other markets around the world.

Commenting on the Judgment, Michael Laurier, CEO of Symphony said "We firmly believe that we were right to challenge this amendment to the draft Directive, and maintain that we should have received compensation for the confusion caused. We will continue our communications programme to explain the value of d2w biodegradable technology to protect the environment around the world from persistent plastic litter.

Symphony is heavily invested in a number of exciting territories around the world for our d2w and d2p technologies, and whilst it is frustrating that this Judgment makes it more challenging to sell d2w in the EU, the Group has a good pipeline of global opportunities for d2w, and we remain confident of communicating further progress in the coming months."

 

 

Enquiries

Symphony Environmental Technologies Plc

+44 (0) 20 8207 5900

Michael Laurier, CEO

Ian Bristow, CFO

www.symphonyenvironmental.com

 

Zeus (Nominated Adviser and Broker)

+44 (0) 203 829 5000

David Foreman / Kieran Russell (Investment Banking)

NOTES TO EDITORS:

About Symphony Environmental Technologies plc

www.symphonyenvironmental.com

 

D2W TECHNOLOGY

Symphony has developed a biodegradable plastic technology which addresses the problem of persistent microplastics, by turning ordinary plastic at the end of its service-life into a waxy substance which is biodegradable. It is then no longer a plastic and can be bioassimilated in the open environment in a similar way to a leaf without leaving microplastics behind. See https://www.symphonyenvironmental.com/why-biodegradable/ The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world, much of which has been recycled. In some countries, oxo-biodegradable plastic is mandatory for short-life plastic products.

d2w technology was studied for three years in the Oxomar project, sponsored by the French government, which concluded that plastic made with Symphony's d2w oxo-biodegradable technology will biodegrade in seawater significantly more efficiently than conventional plastic. See www.biodeg.org/subjects-of-interest/agriculture-and-horticulture/the-marine-environment/

Following this report, the scientists allowed bacteria commonly found in the open environment access to d2w oxo-biodegradable plastic containing Carbon 13. They found Carbon 13 in the carbon dioxide exhaled by the bacteria, proving beyond doubt that the plastic had been bioassimilated by the bacteria.

D2P TECHNOLOGY

Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p® ("designed to protect") trademark, which can be incorporated in a wide variety of plastic and non-plastic products so as to provide protection against many different types of bacteria, viruses, fungi, algae, moulds, and insects, and against fire. See www.d2p.net d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. For an overview see www.d2p.net Symphony has launched d2p anti-microbial household gloves and toothbrushes and "Symfresh" food-packaging and is developing a range of other d2p finished-products for retail sale.

D2C TECHNOLOGY

Symphony has complemented its d2w and d2p product ranges with d2c "compostable resins and products" that have been tested to US and EU composting standards and has invested in Eranova - a French company extracting starch for making plastics out of algae.

D2DETECTOR

Symphony has also developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. This is useful for government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security.

SYMPHONY'S BUSINESS

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

Symphony is a founder-member of The BPA (www.biodeg.org) and actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv See also Symphony on Instagram. A Symphony App is available for downloading to smartphones.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURUKVBRSVUURRR
Date   Source Headline
23rd Apr 20244:36 pmRNSHolding(s) in Company
19th Apr 202411:16 amRNSResult of GM
3rd Apr 20242:00 pmRNSDirector dealing
28th Mar 20244:23 pmRNSResult of PrimaryBid Offer
28th Mar 20242:18 pmRNSHolding(s) in Company
25th Mar 20243:02 pmRNSReplacement - Subscription and Notice of GM
22nd Mar 20247:01 amRNSPrimaryBid Offer
22nd Mar 20247:00 amRNSSubscription, PrimaryBid Offer and Notice of GM
14th Mar 20247:00 amRNSExtension to Convertible Loan Agreements
13th Mar 20247:00 amRNSUS Environmental Protection Agency positive report
9th Feb 20247:59 amRNSEU Judgment – Company Response
31st Jan 20249:48 amRNSEU Court Judgement
18th Jan 20247:00 amRNSTrading Update and EU Case
8th Jan 20247:00 amRNSGrant of options and PDMR dealing
2nd Jan 20247:00 amRNSDirector appointment & grant of options
28th Dec 20237:00 amRNSOptions amendments
18th Oct 20232:10 pmRNS£1.0m convertible loan agreement
29th Sep 20237:00 amRNSInterim Results
26th Sep 20237:00 amRNSYemen Enforces Oxo-Biodegradable Plastic Law
11th Aug 20237:00 amRNSDirectorate Change
1st Aug 20237:00 amRNSPre-close Trading Update
4th Jul 20237:00 amRNSDirectorate Change
29th Jun 20231:46 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
7th Jun 20238:34 amRNSPosting of Annual Report & Accounts & AGM Notice
30th May 20237:00 amRNSPreliminary Results
21st Mar 20237:00 amRNSEU court hearing
13th Mar 20233:40 pmRNSConvertible loan agreement & revenue update
9th Mar 20237:00 amRNSd2w BioBottles supply agreement with TricorBraun
23rd Dec 20227:00 amRNSTrading update
31st Oct 20227:00 amRNSAttendance at world’s leading plastics trade fair
28th Oct 20222:51 pmRNSDirector/PDMR Shareholdings – Option amendments
29th Sep 20229:00 amRNSInvestor Presentation
29th Sep 20227:01 amRNSSymphony India operations update
29th Sep 20227:00 amRNSInterim results for the 6 m/e 30 June 2022
9th Aug 20227:00 amRNSMexican Technical Standard Validating d2w
8th Aug 20227:00 amRNSAgreement for Middle East manufacturing
1st Aug 20227:01 amRNSEquity subscription and grant of warrants
1st Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSd2p Anti-Insect Sales
29th Jun 20222:00 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
28th Jun 20227:00 amRNSd2p Supply Agreement with Grupo Bimbo
27th Jun 20227:00 amRNSPeru legal action outcome
7th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSAppointment of Executive Director
4th May 20227:00 amRNSGrant of Options
20th Apr 20227:00 amRNSSymphony India Sustainability Award
30th Mar 20227:00 amRNSPreliminary results
24th Feb 20223:49 pmRNSExtension of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.